| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Antibodies | ||
| Anti-SARS-CoV Spike Antibody pAb | Sino Biological Inc. | Cat #40150-V08B1 |
| Anti-SARS-CoV-2 Spike antibody pAb | Sino Biological Inc. | Cat #40591-T62 |
| Anti-SARS-CoV Spike antibody (1A9) | GeneTex | Cat #GTX632604 |
| Anti-SARS-CoV nucleocapsid protein polyclonal rabbit antibody | Prospec | Cat # ANT-180 |
| Anti-hPIV2 NP (20A) mAb | Tsurudome et al. (1989) | N/A |
| Anti-hPIV2 P (211A) mAb | Tsurudome et al. (1989) | N/A |
| Anti-hPIV2 P/V (315-1) mAb | Nishio et al. (1997) | N/A |
| Anti-GAPDH, Monoclonal antibody Peroxidase Conjugated | FUJIFILM Wako Pure chemical | Cat #015-25473 |
| Anti-rabbit IgG, HRP-linked Antibody | Cell Signaling Technology | Cat #7074 |
| Anti-mouse IgG, HRP-linked Antibody | Cell Signaling Technology | Cat #7076 |
| Goat Anti-Mouse IgG H&L Alexa Flour488 | Abcam | Cat #Ab150113 |
| Goat Anti-Rabbit IgG H&L Alexa Flour568 | Abcam | Cat #Ab175471 |
| HRP-Goat anti mouse IgG | BioLegend | Cat #405306 |
| anti-Mouse-IgA HRP | Southern Biotech | Cat #1040-05 |
| Anti-mouse CD28 (37.51) | BioLegend | Cat #102115 |
| PerCP/Cyanine5.5 anti-mouse CD4 Antibody (GK1.5) | BioLegend | Cat #100434 |
| PerCP/Cyanine5.5 anti-mouse CD8a Antibody (53-6.7) | BioLegend | Cat #100734 |
| PE anti-mouse IFN-γ Antibody (XMG1.2) | BioLegend | Cat #505808 |
| Biotinylated anti-rabbit IgG antibody | Vector Laboratory | Cat #BA-1000-1.5 |
| Bacterial and virus strains | ||
| BC-PIV | Ohtsuka et al. (2019) | N/A |
| BC-PIV/S1 | This paper | N/A |
| BC-PIV/S1M | This paper | N/A |
| BC-PIV/S-2P | This paper | N/A |
| BC-PIV/S-2PM | This paper | N/A |
| SARS-CoV-2 (UT-NCGM02) | Imai et al. (2020) | N/A |
| SARS-CoV-2 Wuhan strain (NC002) | This paper | N/A |
| SARS-CoV-2 β strain (B.1.351; MD-HP0154) | This paper | N/A |
| SARS-CoV-2 δ strain (B.1.617.2; UW-5250) | This paper | N/A |
| Biological samples | ||
| Guinea Pig erythrocyte | Japan Bio Serum | Cat #35-0012 |
| Chemicals, peptides, and recombinant proteins | ||
| X-treme GENE HP | Roche | Cat #06366244001 |
| DAPI | Nacalai Tesque | Cat #19174-31 |
| Brefeldin A | Biolegend | Cat #420601 |
| SARS-CoV-2 Spike Glycoprotein | GenScript | Cat #RP30020 |
| SARS-CoV-2 Spike S1 Protein | Sino Biological Inc. | Cat #40591-V02H |
| SARS-CoV-2 Spike Protein RBD | Sino Biological Inc. | Cat #40592-V02H |
| Human ACE2 Protein | AcroBiosystems | Cat #AC2-H5257 |
| Dako REAL EnVision Detection System | Dako | Cat #K5007 |
| Critical commercial assays | ||
| SARS-CoV-2 Surrogate Virus Neutralization Test Kit | GenScript | Cat #L00847 |
| eBioscience™ Intracellular Fixation & Permeabilization Buffer Set | Thermo Fisher Scientific | Cat #88-8824-00 |
| Experimental models: Cell lines | ||
| Monkey: Vero | Riken BRC CELL BANK | Cat #RCB0001 |
| Monkey: Vero/BC-F | Ohtsuka et al. (2014) | N/A |
| Monkey: VeroE6/TMPRSS2 | JCRB | Cat #1819 |
| Experimental models: Organisms/strains | ||
| Mouse: BALB/c | Japan CLEA | N/A |
| Hamster: Syrian | Japan SLC | N/A |
| Oligonucleotides | ||
| pcDNA/SARS-CoV-2 S Fw: CAGTGTGGTGGAATTCATGTTTGTGTTCCTGGTGCTG |
This paper | N/A |
| pcDNA/SARS-CoV-2 S Rv : GATATCTGCAGAATTCTCAGGTGTAGTGCAGTTTCAC |
This paper | N/A |
| Vec/SARS-CoV-2 Fw 1: TCTCTATCTGCGGCCGCATATATGTTTGTGTTCCTGGTGCTG |
This paper | N/A |
| Vec/SARS-CoV-2 Fw 2: TCTCTATCTGCGGCCGCAATGTTTGTGTTCCTGGTGCTG |
This paper | N/A |
| Vec/SARS-CoV-2 Rv: AATAGAGATGCGGCCGCCTAACCCGTCCGGGCCTATG |
This paper | N/A |
| SARS-CoV-2 S1/S2 Fw: GAGGGCAAGGTCTGTGGCAAGCCAGAGCATC |
This paper | N/A |
| SARS-CoV-2 S1/S2 Rv: TTGCCACAGACCTTGCCCTCCTTGGGCTGTTG |
This paper | N/A |
| SARS-CoV-2 S2P Fw: ACTGGACCCCCCCGAGGCTGAGGTCCAGATTGAC |
This paper | N/A |
| SARS-CoV-2 S2P Rv: CAGCCTCGGGGGGGTCCAGTCTGCTCAGGATGTC |
This paper | N/A |
| PIV2 F/M Fw: ATAGCATTAATACTATCAGTG |
This paper | N/A |
| SARS-CoV-2 S1/PIV2 F /M Rv: CACTGATAGTATTAATGCTATTGGGCTGTTGGTCTGGGTCTG |
This paper | N/A |
| SARS-CoV-2 S/PIV2 F/M Rv: ACTGATAGTATTAATGCTATTGGCCACTTGATGTATTGTTC |
This paper | N/A |
| PIV2 IG Fw: CTCTCATAATTTAAGAAAAAATC |
This paper | N/A |
| SARS-CoV-2 S1/PIV2 IG Rv: TTTTTCTTAAATTATGAGAGTTATGGGCTGTTGGTCTGGGTC |
This paper | N/A |
| SARS-CoV-2 S/PIV2 IG Rv: TTTTTCTTAAATTATGAGAGTCAGGTGTAGTGCAGTTTCAC |
This paper | N/A |
| Recombinant DNA | ||
| pCMV3-2019-nCoV-S1-long | Sino Biological Inc. | Cat #VG40591-UT |
| pCMV3-2019-nCoV-S2-long | Sino Biological Inc. | Cat #VG40590-UT |
| pcDNA3.1 | Invitrogen | Cat #V79020 |
| pcDNA-SARS-CoV-2 S | This paper | N/A |
| pcDNA-SARS-CoV-2 S-2P | This paper | N/A |
| phPIV2ΔF (BC-PIV) | Ohtsuka et al. (2014) | N/A |
| phPIV2ΔF-SARS-CoV-2 S1 (BC-PIV/S1) | This paper | N/A |
| phPIV2ΔF-SARS-CoV-2 S1M (BC-PIV/S1M) | This paper | N/A |
| phPIV2ΔF-SARS-CoV-2 S-2P (BC-PIV/S-2P) | This paper | N/A |
| phPIV2ΔF-SARS-CoV-2 S-2PM (BC-PIV/S-2PM) | This paper | N/A |
| pCAGGS-PIV2 NP | Ohtsuka et al. (2014) | N/A |
| pCAGGS-PIV2 P | Ohtsuka et al. (2014) | N/A |
| pCAGGS-PIV2 L | Ohtsuka et al. (2014) | N/A |
| SRα-T7 | Ohtsuka et al. (2014) | N/A |
| Software and algorithms | ||
| FlowJo (version 7.2.5) | BD Biosciences | N/A |
| R (version 4.0.2) | The R Foundation | https://www.r-project.org/ |